CN102327464A - Medicament for treating insomnia - Google Patents

Medicament for treating insomnia Download PDF

Info

Publication number
CN102327464A
CN102327464A CN201110302947A CN201110302947A CN102327464A CN 102327464 A CN102327464 A CN 102327464A CN 201110302947 A CN201110302947 A CN 201110302947A CN 201110302947 A CN201110302947 A CN 201110302947A CN 102327464 A CN102327464 A CN 102327464A
Authority
CN
China
Prior art keywords
parts
medicament
medicine
traditional chinese
insomnia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201110302947A
Other languages
Chinese (zh)
Other versions
CN102327464B (en
Inventor
张运林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rudong Wenyuan Investment And Development Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011103029474A priority Critical patent/CN102327464B/en
Publication of CN102327464A publication Critical patent/CN102327464A/en
Application granted granted Critical
Publication of CN102327464B publication Critical patent/CN102327464B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to a medicament for treating insomnia. The medicament comprises the following raw material medicaments in part by weight: 10 to 20 parts of glossy privet fruit, 10 to 20 parts of root of rehmannia, 10 to 20 parts of dwarf lilyturf tuber, 10 to 20 parts of spina date seed, 5 to 10 parts of stiff silkworm, 5 to 10 parts of wall lizard, 5 to 10 parts of gleditsia thorn, 5 to 10 parts of eucommia, 5 to 10 parts of polygonum multiflorum, 5 to 10 parts of arillus longan, 10 to 20 parts of common selfheal fruit-spike, 10 to 20 parts of white paeony root, 5 to 10 parts of dragon's blood and 10 to 20 parts of pearl. The medicament has the advantages that: the medicament is formulated after long-term clinical application and adjustment according to basic theories of traditional Chinese medicine and modern pharmacological research of traditional Chinese medicines, and has reasonable compatibility and precise and appropriate using amounts. The medicament belongs to a Chinese medicinal preparation, has a quick effect and an obvious curative effect and has the advantage of eradicating diseases.

Description

A kind of medicine of Cure for insomnia
 
Technical field
The present invention relates to technical field of Chinese medicines, particularly a kind of medicine of Cure for insomnia.
Background technology
Insomnia is a kind of common disease, and performance has difficulty falling asleep, sleeps and easy waking up, and this disease makes people's brain can not get abundant rest, and health is tired, has a strong impact on patient's working and learning.Causing the reason of insomnia a lot, mainly is that rhythm of life is accelerated, and operating pressure increases, and psychology, the social factor of striving aspects such as fierceness unexpectedly cause.
At present the Western medicine of Cure for insomnia is main with tranquilizing soporific mainly, and all calmness, hypnotic medicine all produce dependency to some extent, after the drug withdrawal, and symptomatic recurrence, life-time service can develop immunity to drugs.
It is main that the Chinese medicine of Cure for insomnia is mainly calmed the nerves with replenishing blood for nourishing heart, is the Chinese patent of CN1698791A like publication number, is the Chinese patent of CN1706436 like publication number, or the like.Said medicine all has certain curative effect, but it is slow all to have an onset, the shortcoming that need take for a long time.
Summary of the invention
In order to solve the deficiency of above technical elements, the invention provides a kind of rapid-action, evident in efficacy, as can to eradicate the Cure for insomnia of disease advantage medicine that has.
The present invention realizes in the following manner:
A kind of medicine of Cure for insomnia, the weight proportion of each crude drug is following:
Fructus Ligustri Lucidi 10-20 part, Radix Rehmanniae 10-20 part, Radix Ophiopogonis 10-20 part, Semen Ziziphi Spinosae 10-20 part, Bombyx Batryticatus 5-10 part; Gekko Swinhonis 5-10 part, Spina Gleditsiae 5-10 part, Cortex Eucommiae 5-10 part, Radix Polygoni Multiflori 5-10 part, Arillus Longan 5-10 part; Spica Prunellae 10-20 part, Radix Paeoniae Alba 10-20 part, Sanguis Draxonis 5-10 part, Margarita 10-20 part.
Fructus Ligustri Lucidi: liver and kidney tonifying; Clearind deficient heat; Make eye bright.
The Radix Rehmanniae: clearing away heat and cooling blood, yin nourishing is promoted the production of body fluid.
Radix Ophiopogonis: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.
Semen Ziziphi Spinosae: nourishing the liver, mind calming is calmed the nerves, arresting sweating.
Bombyx Batryticatus: expelling wind for relieving convulsion, dissipating phlegm and resolving masses.
Gekko Swinhonis: dispel the wind, active, eliminating stagnation.
Spina Gleditsiae: suffering, temperature.Return liver, stomach warp, the evacuation of pus of drawing out pus by applying a plaster to the affected part, promoting blood circulation and detumescence.
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, antiabortive.
Radix Polygoni Multiflori: detoxifcation, eliminating carbuncle, loosening bowel to relieve constipation.
Arillus Longan: invigorating the heart and spleen, nourishing blood to tranquillize the mind.
Spica Prunellae: relieving inflammation or internal heat makes eye bright, clearing away liver-fire, blood pressure lowering, mass dissipating and swelling eliminating
The Radix Paeoniae Alba: nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.
Sanguis Draxonis: dissipating blood stasis analgesic therapy, hemostasia and promoting granulation.
Margarita: feel at ease, make eye bright.
Beneficial effect of the present invention: medicine of the present invention is according to Basic Theories of Chinese Medicine, Chinese medicine modern pharmacological research, and long-term clinical is worked out with the adjustment back, and compatibility is reasonable, and consumption is precise and appropriate.Medicine of the present invention belongs to pure Chinese medicinal preparation, has rapid-actionly, evident in efficacy, can eradicate the advantage of disease.
The specific embodiment
Embodiment 1
A kind of medicine of Cure for insomnia, the weight proportion of each crude drug is following:
10 parts of Fructus Ligustri Lucidi, 20 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Semen Ziziphi Spinosaes, 5 parts of Bombyx Batryticatus, 10 parts of Gekko Swinhonis, 5 parts of Spina Gleditsiae, 10 parts of the Cortexs Eucommiae, 5 parts of Radix Polygoni Multiflori, 10 parts of Arillus Longans, 10 parts of Spica Prunellaes, 20 parts of the Radix Paeoniae Albas, 5 parts of Sanguis Draxonis, 20 parts of Margaritas.
Manufacturing method for above mentioned medicine is:
(1) take by weighing raw material in the prescription, place extraction pot, add the water of 8 times of weight, soaked 30 minutes, be heated to water and open back slow fire boiling 2 hours, filter, filtering residue adds 5 times of weight water, repeats above operation, merging filtrate;
(2) filtrating is left standstill, got supernatant, heating is concentrated into relative density 1.10 (60 ℃ of surveys), and spray drying (EAT 160-175 ℃, leaving air temp 85-95 ℃) gets dry extract;
(3) the gained dry extract is put in order with shaking screen, crossed 80 mesh sieves, the gained defective material that will sieve is in addition pulverized with Highefficientpulverizer; Still with the shaking screen arrangement, cross 80 mesh sieves, the gained medicated powder that will sieve merges; Mixed 30 minutes with mixer, be distributed into the 3g/ bag, promptly get after the sterilization.
Usage and consumption: oral, 2 times on the one, each 2 bags.15 days courses of treatment, totally three courses of treatment.
Embodiment 2
A kind of medicine of Cure for insomnia, the weight proportion of each crude drug is following:
20 parts of Fructus Ligustri Lucidi, 10 parts in the Radix Rehmanniae, 20 parts of Radix Ophiopogonis, 10 parts of Semen Ziziphi Spinosaes, 10 parts of Bombyx Batryticatus, 5 parts of Gekko Swinhonis, 10 parts of Spina Gleditsiae, 5 parts of the Cortexs Eucommiae, 10 parts of Radix Polygoni Multiflori, 5 parts of Arillus Longans, 20 parts of Spica Prunellaes, 10 parts of the Radix Paeoniae Albas, 10 parts of Sanguis Draxonis, 10 parts of Margaritas.
Method for preparing and usage and dosage are with embodiment 1.
Clinical trial result
1, case data
Accept out-patient's 200 examples for medical treatment, wherein male 88 examples, women 112 examples, age 20-30 year 33 examples, 30-40 year 49 examples, 40-50 year 101 examples, 50-60 year 17 examples.
2, diagnostic criteria
Insomnia belongs to nervous system disease; It is neurosal morbidity performance; On pathomorphology, still can not make sure checking to this type of disease both at home and abroad; The measuring means of also do not have reason, changing goes to confirm criterion of therapeutical effect, can only rely on patient's main suit and the observation of doctor to patient's Signs, makes the foundation of judgement pharmaceutical effectiveness.
3, Therapeutic Method
Of the present invention group: patient's 100 examples, the medicine that uses the embodiment of the invention 1 to make, oral, 2 times on the one, each 2 bags, 15 days courses of treatment, observe three courses of treatment altogether.
Matched group: patient's 100 examples, use to use now and more extensively, generally reflect the Zaleplon tablet that therapeutic effect is good, one time 1, take before sleeping, observed altogether 45 days.
4, efficacy assessment standard
1. cure: reach the length of one's sleep about 7-8 hour;
2. take a turn for the better: increase sleep about 2-3 hour;
3. do not have change: the back of taking medicine is invalid;
4. increase the weight of: the back state of an illness of taking medicine increases the weight of.
5, therapeutic outcome
Following table 1 is of the present invention group of therapeutic outcome statistical table with matched group
Table 1 therapeutic outcome statistical table
? Cure Take a turn for the better Do not have and change Increase the weight of Effective percentage
Of the present invention group 81 19 0 0 100%
Matched group 64 24 11 1 88%
Effective percentage=(cure quantity+improvement quantity)/case sum * 100% wherein.
It is thus clear that medicine of the present invention is compared with the Zaleplon tablet, it is high a lot of that cure rate is wanted, and effective percentage reaches 100%, has no side effect.
The typical clinical case
Case 1: grandson so-and-so, man, 28 years old; IT engineer, the irregular serious insomnia that causes of secular operating pressure and daily schedule shows as 2:00 AM and has difficulty in going to sleep basically before; Can not sleep soundly after sleeping, have a dream again and again, the length of one's sleep of every day is generally about 4 hours; Energy did not recover after sleeping, and once used a variety of Drug therapys, and fruit does not take effect.Use medicine of the present invention after course of treatment, sleep quality obviously improves, and has a dream no longer again and again; Energy is good more a lot of than in the past after waking up, and continues to use medicine of the present invention, after total the 3rd course of treatment; Extend to 7 hours the length of one's sleep, uses again after three courses of treatment, extends to 8 hours the length of one's sleep; Sleep quality obviously improves, and energy is also vigorous, and work efficiency has had large increase.Followed up a case by regular visits to six months, and do not have recurrence.
Case 2: poplar, the woman, 53 years old, be in climacteric, be prone to agitation, often be with anger sleeping, have only 2-3 hour the length of one's sleep, bad dream again and again.Take medicine of the present invention after course of treatment, the length of one's sleep, irritated emotion is eased; Sleep quality has had large increase; No longer often have horrible nightmares, extend to 5 hours the length of one's sleep, continues to use medicine to the of the present invention during four courses of treatment; Can reach 7-8 hour the length of one's sleep, and involutional symptom there be alleviating to a certain degree.Followed up a case by regular visits to six months, and do not have recurrence.
Case 3: the king so-and-so, the woman 38 years old, suffers from insomnia 3 years; Show as difficulty falling asleep, early awakening can't be fallen asleep after waking up again, takes medicine of the present invention after course of treatment; The early awakening symptom is obviously improved, even if early awakening, can also reenter and sleep 1-2 hour; After taking three courses of treatment, reach 7 hours the length of one's sleep, is almost recovered.Followed up a case by regular visits to six months, and do not have recurrence.
It is thus clear that Drug therapy insomnia instant effect of the present invention, therapeutic effect is good, is a kind of medicine that the use prospect is arranged very much.

Claims (1)

1. the medicine of a Cure for insomnia is characterized in that the weight proportion of each crude drug is following:
Fructus Ligustri Lucidi 10-20 part, Radix Rehmanniae 10-20 part, Radix Ophiopogonis 10-20 part, Semen Ziziphi Spinosae 10-20 part, Bombyx Batryticatus 5-10 part; Gekko Swinhonis 5-10 part, Spina Gleditsiae 5-10 part, Cortex Eucommiae 5-10 part, Radix Polygoni Multiflori 5-10 part, Arillus Longan 5-10 part; Spica Prunellae 10-20 part, Radix Paeoniae Alba 10-20 part, Sanguis Draxonis 5-10 part, Margarita 10-20 part.
CN2011103029474A 2011-10-10 2011-10-10 Medicament for treating insomnia Active CN102327464B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103029474A CN102327464B (en) 2011-10-10 2011-10-10 Medicament for treating insomnia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103029474A CN102327464B (en) 2011-10-10 2011-10-10 Medicament for treating insomnia

Publications (2)

Publication Number Publication Date
CN102327464A true CN102327464A (en) 2012-01-25
CN102327464B CN102327464B (en) 2013-05-15

Family

ID=45479595

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103029474A Active CN102327464B (en) 2011-10-10 2011-10-10 Medicament for treating insomnia

Country Status (1)

Country Link
CN (1) CN102327464B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107319523A (en) * 2017-06-23 2017-11-07 天津金匮堂生物科技有限公司 A kind of insufficiency of heart yin that improves causes health products of insomnia and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679909A (en) * 2005-01-26 2005-10-12 陈卫辉 Chinese medicine composition for treating hyposomnia and preparation thereof
CN1973889A (en) * 2006-11-07 2007-06-06 任广来 Insomnia treating Chinese medicine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679909A (en) * 2005-01-26 2005-10-12 陈卫辉 Chinese medicine composition for treating hyposomnia and preparation thereof
CN1973889A (en) * 2006-11-07 2007-06-06 任广来 Insomnia treating Chinese medicine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
于川: "治疗失眠方剂的配伍规律探析", 《中华中医药学刊》, vol. 25, no. 6, 30 June 2007 (2007-06-30), pages 1204 - 1205 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107319523A (en) * 2017-06-23 2017-11-07 天津金匮堂生物科技有限公司 A kind of insufficiency of heart yin that improves causes health products of insomnia and preparation method thereof

Also Published As

Publication number Publication date
CN102327464B (en) 2013-05-15

Similar Documents

Publication Publication Date Title
CN101327297B (en) Chinese medicine composition for treating insomnia
CN102283999B (en) Traditional Chinese medicine preparation for treating insomnia
CN102198241B (en) Medicine for alleviating nervousness and taking care of sub-health
CN101708281B (en) Chinese medicinal preparation for nourishing heart and tranquilizing mind and preparation method thereof
CN102895501A (en) Drug for the treatment of insomnia
CN105999130A (en) Traditional Chinese medicinal composition for treating insomnia, and preparation method thereof
CN103550495A (en) Traditional Chinese medicine composition for treating insomnia
CN103330835A (en) Traditional Chinese medicine composition for treating climacteric syndromes
CN101239177A (en) Chinese medicinal composition for curing alopecia, generating hair and blackening hair and its manufacturing method
CN102698091B (en) Traditional Chinese medicine oral liquid for relieving neurasthenia and preparation method
CN102327464B (en) Medicament for treating insomnia
CN102406784B (en) Traditional Chinese medicine composition for treating insomnia
CN101745048B (en) Medicine for treating type II diabetes and resisting aging
CN103735871A (en) Chinese medicinal composition for treating neurasthenia and preparation method thereof
CN102793845B (en) Traditional Chinese medicine composition for treating climacteric syndrome
CN102319406B (en) Medicament for treating tristimania
CN104825650A (en) Nerves-soothing brain-strengthening oral liquid
CN102091163B (en) Chinese medicine composition for treating diabetic heart disease
CN104189587A (en) Traditional Chinese medicine preparation capable of nourishing yin and suppressing excessive yang for treating epilepsy and preparation method of traditional Chinese medicine preparation
CN104758674A (en) Traditional Chinese medicine composition for treating insomnia
CN100402077C (en) Medicinal composition for treating hyperosteogency
CN102178770A (en) Traditional Chinese medicinal composite for treating gastroptosis
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
CN101279007A (en) Chinese medicine for curing aconuresis
CN1358508A (en) Capsule for tonifying kidney and tranquilization

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: WEI SHAOLIANG

Free format text: FORMER OWNER: ZHANG YUNLIN

Effective date: 20130409

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Wei Shaoliang

Inventor before: Zhang Yunlin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: ZHANG YUNLIN TO: WEI SHAOLIANG

Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 272000 JINING, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20130409

Address after: 272000 Jining City Hospital of traditional Chinese medicine, three ring road north, Jining, Shandong

Applicant after: Wei Shaoliang

Address before: 250000 Shandong Province Flyover District of Ji'nan City shadowless Hill Road No. 114

Applicant before: Zhang Yunlin

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUDONG TECHNOLOGY CENTER

Free format text: FORMER OWNER: WEI SHAOLIANG

Effective date: 20131211

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272000 JINING, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131211

Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong

Patentee after: Rudong science and Technology Center

Address before: 272000 Jining City Hospital of traditional Chinese medicine, three ring road north, Jining, Shandong

Patentee before: Wei Shaoliang

TR01 Transfer of patent right

Effective date of registration: 20200426

Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province

Patentee after: Rudong industrial and commercial information consulting service center

Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong

Patentee before: Rudong science and Technology Center

TR01 Transfer of patent right
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20211126

Address after: Fengli town Xinjian West Road, Rudong County, Nantong City, Jiangsu Province 226400

Patentee after: Rudong Wenyuan investment and Development Co., Ltd

Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province

Patentee before: Rudong industrial and commercial information consulting service center